logo
  

London Metric Buys Three Urban Logistics Warehouses For 35.4 Mln Pounds

London Metric Property Plc (LMP.L), which owns and manages real estate, on Tuesday announced acquisition of three urban logistics warehouses for 35.4 million pounds.

The properties generate a yearly rent revenue of 1.7 million pounds with 83 percent of the income benefiting from RPI or CPI linked rent review, the London-based company said in a statement.

The newly acquired warehouses have a weighted average unexpired lease term or WAULT of 15 years. The 130000 square feet property in Worthing, has been purchased for 19.0 million pounds through a sale and leaseback transaction with Bowers & Wilkins. The occupier has approved a new 15-year lease with rent reviews linked to CPI.

The 50,000 square feet building in Uckfield, was acquired for 10.3 million pounds and let to John Lewis for a further 15 years with RPI linked rent reviews.

The third 47,000 square feet property in Exeter was purchased for 6.1 million pounds and let to Jewson for a further 17 years, with the next review in March 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT